Category Archives for "drug product injuries"

Feb 24

Sloan Kettering Study Confirms Connection Between Zantac (ranitidine) and Cancer-Causing NDMA

By Angela Leone

Zantac Cancer Lawsuit

A new study authored by Dr. Lior Z. Braunstein, MD of Memorial Sloan Kettering Cancer Center and published in The Journal of the American Medical Association (JAMA) has confirmed a correlation between acid reflux treatment ranitidine (brand name ZANTAC) and the cancer causing substance N-nitrosodimethylamine, or NDMA. The study created conditions in which ranitidine might […]

Continue reading
Apr 27

Zantac Recall: What is NDMA and Why is it Dangerous?

By Lee Rosenfeld

zantac cancer lawsuits, zantac cancer lawyers, zantac recall,

If you’ve watched the news at all recently, you’ve likely heard about the Zantac Recall. Zantac, a very common and now recalled antacid medication, is now considered dangerous to humans because it is linked to a dangerous chemical impurity known as NDMA (N-Nitroso-dimethylamine). Zantac Recall: What is NDMA? NDMA is a yellow liquid which has […]

Continue reading
Apr 01

Zantac ordered off the shelves by FDA due to Cancer causing NDMA

By Joe Messa

The U.S. Food and Drug Administration (FDA) issued a press release today requesting that manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This comes months after the FDA announced its initial warning regarding ranitidine medications (brand name ZANTAC) and the possible presence of a contaminant known as N-Nitrosodimethylamine (NDMA). NDMA […]

Continue reading
Jan 25

ARB Blood Pressure Medicine Recalls Expanding

By Joe Messa

Since late last year, several pharmaceutical companies have been slowly recalling various lots of blood pressure medications containing valsartan, irbesartan, or losartan. The recalled drugs are believed to potentially contain an impurity called N-nitrosodiethylamine (NDEA). NDEA is a known animal and probable human carcinogen (Group 2A) most often found in tobacco smoke. The medications involved […]

Continue reading
Dec 06

RECALL: Infant Ibuprofen sold at Walmart, CVS, and Family Dollar

By Joe Messa

Tris Pharma, Inc., a New Jersey based pharmaceutical manufacturer, has issued a voluntary recall of infant ibuprofen that may contain higher concentrations than noted on the bottle, leading to potential risks in infants. The impacted lots of medication were sold to a distributor that supplies retailers, including CVS, Walmart, and Family Dollar. Retailers and wholesalers […]

Continue reading
1 2 3 … 9